GlassScriptPrepare for your visit
Yvana Cespedes
Dermatopathology (Pathology) · Lexington, MA · NPI 1518926864
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,428.30
in general payments reported to CMS, 2019-2025 · $178 in 2025
The $178 reported for 2025 was more than what a typical Dermatopathology (Pathology) provider received nationally (typical 2025 total: $119).
Who reported paying
General payments only, top 6 by amount.
- Pfizer INC. $281.68
- Genzyme Corporation $249.93
- Janssen Scientific Affairs, LLC $242.67
- Boehringer Ingelheim Pharmaceuticals, INC. $165.12
- E.R. Squibb & Sons, L.L.C. $125.00
- Organogenesis INC. $76.77
Drugs and devices associated with these payments
Sotyktu Spevigo Litfulo Cibinqo Rinvoq Puraply Taltz
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Yvana Cespedes listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/947440/yvana-cespedes